Free Trial
CVE:RX

BioSyent (RX) Stock Price, News & Analysis

BioSyent logo
C$11.38 +0.07 (+0.62%)
As of 08/1/2025 03:59 PM Eastern

About BioSyent Stock (CVE:RX)

Key Stats

Today's Range
C$11.32
C$11.38
50-Day Range
C$11.15
C$12.00
52-Week Range
C$9.20
C$12.13
Volume
8,476 shs
Average Volume
4,144 shs
Market Capitalization
C$130.16 million
P/E Ratio
18.47
Dividend Yield
1.58%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive RX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for BioSyent and its competitors with MarketBeat's FREE daily newsletter.

RX Stock News Headlines

Biosyent Inc. Stock Price History
BioSyent (CVE:RX) Has Announced A Dividend Of CA$0.05
A new rule goes live in July — and the banks are quietly crushing it
A little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Street and the Big Banks… It gives them the green light to treat a certain tangible asset as equivalent to cold, hard cash. Not stocks. Not real estate. And definitely not the U.S. dollar. We're talking about something they don't want you to notice — because the fewer people who act on this, the better it is for them.
BioSyent Inc. (RX.V)
See More Headlines

RX Stock Analysis - Frequently Asked Questions

BioSyent's stock was trading at C$11.00 at the beginning of 2025. Since then, RX stock has increased by 3.5% and is now trading at C$11.38.

BioSyent Inc. (CVE:RX) announced its earnings results on Thursday, May, 25th. The company reported $0.06 earnings per share for the quarter, missing the consensus estimate of $0.08 by $0.02. The company had revenue of $3.82 million for the quarter, compared to analyst estimates of $4.80 million. BioSyent had a net margin of 20.60% and a trailing twelve-month return on equity of 20.01%.

Shares of RX stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

Based on aggregate information from My MarketBeat watchlists, some other companies that BioSyent investors own include Aurora Cannabis (ACB), Astec Industries (ASTE), Bank of Nova Scotia (BNS), Carnival (CCL), Cisco Systems (CSCO), Devon Energy (DVN) and Ford Motor (F).

Company Calendar

Last Earnings
5/25/2017
Today
8/04/2025

Industry, Sector and Symbol

Stock Exchange
CVE
Sector
Medical
Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
N/A
Current Symbol
CVE:RX
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
C$0.62
Trailing P/E Ratio
18.47
Forward P/E Ratio
16.39
P/E Growth
N/A
Net Income
C$7.02 million
Net Margins
20.60%
Pretax Margin
N/A
Return on Equity
20.01%
Return on Assets
12.86%

Debt

Debt-to-Equity Ratio
2.90
Current Ratio
3.92
Quick Ratio
6.91

Sales & Book Value

Annual Sales
C$34.06 million
Price / Sales
3.82
Cash Flow
C$3.70 per share
Price / Cash Flow
3.07
Book Value
C$3.22 per share
Price / Book
3.53

Miscellaneous

Outstanding Shares
11,437,447
Free Float
N/A
Market Cap
C$130.16 million
Optionable
Not Optionable
Beta
0.93
 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report

This page (CVE:RX) was last updated on 8/5/2025 by MarketBeat.com Staff
From Our Partners